Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acticor, Aridis, Ascentage, Cocrystal, IGM, Pepgen, Pharmazz, Precigen, Rocket.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abilita, Ariceum, Cleave, GE Healthcare, Genfit, Impact, Medigene, Mei, Merck & Co., Novan, Nykode, Philogen, Seal Rock, Theragnostics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications:  Abbvie, Abcuro, Adiso, Amgen, Aquestive, Ascendis, Caliway, Canbridge, Celldex, Coave, Glyscend, Horizon, Kahr, Nacuity, Onconano, Pathalys, Precision, Rayzebio, Sanofi, Selecta, Snipr, Travere, Xencor.

New hires and promotions in the biopharma industry, including: Cantargia, IO Biotech, Palisade, Veru.

Biopharmas raising money in public or private financings, including: Effector, Lexicon, Lyra, Oculis, Phion, Pneumagen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: GE Healthcare, Think Surgical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accustem, Cumulus, Intuitive Surgical, Kardium, Microbot, Titan Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neurometrix.

Med-tech firms raising money in public or private financings, including: Boston Scientific.

New hires and promotions in the med-tech industry, including: Ceiba Capital, Sophia Genetics.